Comment on: “Premedication prior to PEG-asparaginase is cost effective in pediatric patients with acute lymphoblastic leukemia”

Wing H. Tong*, Carin A. Uyl-De Groot

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorProfessionalpeer-review

Original languageEnglish
Article numbere29474
JournalPediatric Blood and Cancer
Issue number4
Publication statusAccepted/In press - 10 Dec 2021

Cite this